Sutton Wealth Advisors Inc. Novartis Ag Transaction History

Sutton Wealth Advisors Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$80.03 - $92.81 $150,616 - $174,668	-1,882 Reduced 97.26%	53 $4.88 Million
Q3 2022 Nov 07, 2023	BUY	$74.61 - $87.26 $73,341 - $85,776	983 Added 103.26%	1,935 $147 Million
Q2 2022 Nov 07, 2023	BUY	$80.52 - $93.75 $35,911 - $41,812	446 Added 88.14%	952 $80.5 Million
Q1 2022 Nov 07, 2023	BUY	$80.11 - $90.62 $36,289 - $41,050	453 Added 854.72%	506 $44.4 Million
Q2 2016 Nov 06, 2023	SELL	N/A	-350 Reduced 86.85%	53 $4.37 Million
Q1 2016 Nov 06, 2023	BUY	N/A	403	403 $29.2 Million

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $228B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.